WINNERS & LOSERS: Goodwin jumps; Oxford BioMedica trims revenue view
(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Friday. Read More
| Price | 4,888.00p on 10-08-2026 at 18:35:06 |
|---|---|
| Change | -36.00p -0.73% |
| Buy | 4,900.00p |
| Sell | 4,892.00p |
| Last Trade: | Buy 271.00 at 4,887.3137p |
| Day's Volume: | 87,375 |
| Last Close: | 4,888.00p |
| Open: | 4,694.00p |
| ISIN: | GB0006640972 |
| Day's Range | 4,694.00p - 4,932.00p |
| 52wk Range: | 2,980.00p - 5,135.00p |
| Market Capitalisation: | £1.37b |
| VWAP: | 4,893.687p |
| Shares in Issue: | 28.05m |
4Imprint (FOUR) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 271 | 4,887.3137p | Ordinary |
16:48:15 - 10-Aug-26 |
| Buy* | 307 | 4,895.748p | SI Trade Negotiated Trade |
16:47:04 - 10-Aug-26 |
| Buy* | 10,000 | 4,890.16634p | Suspected BUY Trade |
16:40:33 - 10-Aug-26 |
| Buy* | 10,000 | 4,898.14677p | Suspected BUY Trade |
16:40:30 - 10-Aug-26 |
| Sell* | 6,215 | 4,888.00p | SI Trade |
16:36:41 - 10-Aug-26 |
| Sell* | 6,215 | 4,888.00p | SI Trade |
16:36:41 - 10-Aug-26 |
| Sell* | 76 | 4,888.00p | SI Trade |
16:35:02 - 10-Aug-26 |
| Sell* | 1,842 | 4,888.00p | SI Trade |
16:35:02 - 10-Aug-26 |
| Sell* | 117 | 4,888.00p | SI Trade |
16:35:02 - 10-Aug-26 |
| Sell* | 44 | 4,888.00p | SI Trade |
16:35:02 - 10-Aug-26 |
4Imprint (FOUR) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 5th Aug 2026 7:00 am | RNS | Half-year Financial Report |
| 30th Jun 2026 7:00 am | RNS | Holding(s) in Company |
| 29th Jun 2026 1:40 pm | RNS | Block Listing Interim Review |
| 9th Jun 2026 1:58 pm | RNS | Holding(s) in Company |
| 4th Jun 2026 7:00 am | RNS | Director/PDMR Shareholding |
| 20th May 2026 1:14 pm | RNS | Result of AGM |
| 20th May 2026 7:00 am | RNS | AGM Statement |
| 15th May 2026 8:02 am | RNS | Director/PDMR Shareholding |
| 14th Apr 2026 9:27 am | RNS | Annual Financial Report |
| 25th Mar 2026 2:05 pm | RNS | Director/PDMR Shareholding |